The pharmaceutical market worldwide is undergoing fundamental change. Developed markets are suffering from increased pressure from market competition and increasing costs.

Pharmaceutical companies feel forced to transform their business model into a networked structure where the outsourcing activities are the best way of staying competitive in a market where productivity is decreasing and the costs of remaining innovative are increasing.

CMUs , commonly known as Contract Manufacturing Units play vital role by assisting pharmas to ensure continuous production at reduced costs. Moreso Contract Manufacturing activities help Pharmas in

• reducing time to market;
• providing a back-up position;
• reducing risk and debt;
• providing expertise;
• providing equipment and flexibility (relieves manufacturing constraints);
• providing cost control;
• allowing focus on core activities (refocusing organization, re-engineering processes, accommodating business    downsizing needs, focusing on business-critical tasks);
• providing improved operational quality (increased expertise, benefits from the core business expertise of specialized partners);
• allowing improvement of productivity (economies of scope, increased flexibility, improve time-to- market); and
• providing control of business risk (increased accessto diverse technologies, access to technologies without capital investment, reduced technical obsolescence risk).
  

Blossom Pharmaceuticals is WHO cGMP certified and strictly adheres to

• commitment to quality;
• best practices and standards for WHO cGMP;
• meeting deadlines
• well-trained and experienced staff;
• validated systems and processes;
• experience with new technologies;
• Cost and Quality control
• location ease of interaction;
• technology transfer capability;
• responsiveness to customer demands

To partner with us Or any other enquiry please mail us at

enquiry@blossompharma.com